Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation.
<h4>Objective</h4>To investigate dynamic contrast-enhanced computed tomography for monitoring the effects of regorafenib on experimental colon carcinomas in rats by quantitative assessments of tumor microcirculation parameters with immunohistochemical validation.<h4>Materials and m...
Guardado en:
Autores principales: | Clemens C Cyran, Philipp M Kazmierczak, Heidrun Hirner, Matthias Moser, Michael Ingrisch, Lukas Havla, Alexandra Michels, Ralf Eschbach, Bettina Schwarz, Maximilian F Reiser, Christiane J Bruns, Konstantin Nikolaou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6cfe076e2c15477cb2e62b649289aa55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Regorafenib in metastatic colorectal cancer: more data for clinical decisions
por: Vladislav V. Petkau, et al.
Publicado: (2021) -
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Jianyong Zhuo, et al.
Publicado: (2021) -
Immunohistochemical characterisation of cell-type specific expression of CK1delta in various tissues of young adult BALB/c mice.
por: Jürgen Löhler, et al.
Publicado: (2009) -
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
por: M. I. Sekacheva, et al.
Publicado: (2020) -
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib
por: Flavia Fondevila, et al.
Publicado: (2021)